Clinical-stage biotechnology company, Vaxart, Inc., announced that the first subject has been dosed in its Phase 1 study of VXA-CoV2-1, an oral tablet COVID-19 vaccine candidate. “We are advancing VXA-CoV2-1...

Vaxart, Inc. a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, announced publication of the comprehensive results of...

A microscopic corn-and-shrimp cocktail could eventually make DNA-based vaccinations and cancer-treating gene therapies an easier pill to swallow, according to new research from the University of Nebraska-Lincoln. In...

Researchers from The University of Texas Medical Branch at Galveston have developed a vaccine against salmonella poisoning designed to be taken by mouth. The findings are detailed in an article published...